## Background: Infliximab induces remission and improves the health-related quality of life (hrqol) of patients with refractory or fistulous crohn's disease (cd). however, little information is available as to whether its effect on hrqol is sustained over time. the objective was to measure the hrqo
β¦ LIBER β¦
Infliximab improves quality of life in patients with Crohn's disease
β Scribed by Dr. Gary R. Lichtenstein; Mohan Bala; Chenglong Han; Kimberly DeWoody; Thomas Schaible
- Book ID
- 110086020
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 134 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Sustained improvement of health-related
β
Francesc Casellas; Luis Rodrigo; Pilar NiΓ±o; Carmen Pantiga; Sabino Riestra; Jua
π
Article
π
2007
π
John Wiley and Sons
π
English
β 168 KB
π 2 views
The CHOICE trial: adalimumab demonstrate
β
S. Lichtiger; D. G. Binion; D. C. Wolf; D. H. Present; A. G. Bensimon; E. Wu; A.
π
Article
π
2010
π
John Wiley and Sons
π
English
β 215 KB
Quality improvement in wellness reports
β
Lone G. M. JΓΈrgensen; Henrik Hey; Ivan Brandslund; Martin Eivindson; Ida Vind; H
π
Article
π
2006
π
Springer-Verlag
π
English
β 249 KB
Quality of life rapidly improves with bu
β
Dr. E. Jan Irvine; Gordon R. Greenberg; Brian G. Feagan; Francois Martin; Lloyd
π
Article
π
2000
π
John Wiley and Sons
π
English
β 680 KB
Resource use in patients with Crohnβs di
β
C. SARO; C. DE LA COBA; M. Γ. CASADO; J. M. MORALES; B. OTERO
π
Article
π
2007
π
John Wiley and Sons
π
English
β 123 KB
Rasagiline improves quality of life in p
β
Kevin M. Biglan; Steven Schwid; Shirley Eberly; Karen Blindauer; Stanley Fahn; T
π
Article
π
2006
π
John Wiley and Sons
π
English
β 164 KB
π 1 views
The objective of this study was to determine the effects of rasagiline as monotherapy on quality of life (QOL) in patients with early Parkinson's disease (PD). Rasagiline, a potent, second-generation, irreversible, selective monoamine oxidase B inhibitor improves PD symptoms in patients with early P